Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Kenvue Inc. Common Stock
(NY:
KVUE
)
18.75
+0.09 (+0.46%)
Streaming Delayed Price
Updated: 3:41 PM EST, Feb 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Kenvue Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
The Ultimate Dividend Stock to Buy With $1,000 Right Now
↗
Today 7:45 EST
This Dividend King has an appealing 4.7% dividend yield.
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Economy
What's going on in today's session: S&P500 most active stocks
↗
February 19, 2026
Via
Chartmill
Stock Market Today, Feb. 18: Kenvue Rises After Earnings Beat Expectations
↗
February 18, 2026
On Feb. 18, 2026, investors weighed Kenvue's earnings momentum against looming merger costs and related risks.
Via
The Motley Fool
Topics
Earnings
Stocks
What's going on in today's session: S&P500 most active stocks
↗
February 18, 2026
Via
Chartmill
Kenvue Inc (NYSE:KVUE) Tops Q4 2025 Estimates Amid Pending Kimberly-Clark Acquisition
↗
February 17, 2026
Via
Chartmill
Earnings Summary: Kenvue Q4
↗
February 17, 2026
Via
Benzinga
Kenvue Earnings Preview
↗
February 16, 2026
Via
Benzinga
Kenvue Analysts Boost Their Forecasts After Upbeat Q4 Earnings
↗
February 18, 2026
Via
Benzinga
Kenvue Reports Fourth Quarter and Full Year 2025 Results
February 17, 2026
From
Kenvue
Via
Business Wire
What's going on in today's session: S&P500 most active stocks
↗
February 17, 2026
Via
Chartmill
These S&P500 stocks are the most active in today's session
↗
February 12, 2026
Via
Chartmill
Curious about the most active S&P500 stocks in today's session?
↗
February 10, 2026
Via
Chartmill
These stocks are making the most noise in today's session.
↗
February 10, 2026
Via
Chartmill
Looking for the most active stocks in the S&P500 index on Monday?
↗
February 09, 2026
Via
Chartmill
The Era of the Titans: Q4 2025 Mega-Deal Surge and the 2026 Economic Map
February 06, 2026
As of February 6, 2026, the global financial landscape is still reverberating from a historic tectonic shift that occurred in the final months of last year. In the fourth quarter of 2025, the M&A...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Curious about the most active S&P500 stocks in today's session?
↗
February 05, 2026
Via
Chartmill
These S&P500 stocks are the most active in today's session
↗
February 04, 2026
Via
Chartmill
Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026
February 04, 2026
From
Kenvue
Via
Business Wire
2 of the Safest Ultra-High-Yield Dividend Stocks to Buy Right Now
↗
February 02, 2026
Chevron and Kimberly Clark check all the boxes for generating reliable passive income from dividend stocks.
Via
The Motley Fool
All It Takes Is $13,000 Invested in Each of These 2 Dividend Kings to Help Generate $1,000 in Passive Income in 2026
↗
February 01, 2026
Consumer staples stocks being out of favor is an impeccable buying opportunity for value investors.
Via
The Motley Fool
Topics
Earnings
Looking for Passive Income in 2026? 3 Dividend Kings to Buy Hand Over Fist
↗
January 31, 2026
These market giants make great long-term investments.
Via
The Motley Fool
1 Super-Safe High-Yield Dividend King Stock to Buy Even if There's a Stock Market Sell-Off in 2026
↗
January 31, 2026
Near a 12-year low, Kimberly-Clark may be one of the best deep value stocks for income investors to buy in 2026.
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
World Trade
Kimberly-Clark's Mega-Bid for Kenvue: A $48.7 Billion Consumer Staples Shakeup
January 28, 2026
In a move that signals a seismic shift within the consumer staples landscape, Kimberly-Clark (NYSE:KMB) is on the precipice of finalizing its $48.7 billion acquisition of Kenvue (NYSE:KVUE). This...
Via
MarketMinute
Topics
Economy
What's going on in today's session: S&P500 most active stocks
↗
January 28, 2026
Via
Chartmill
Kenvue Declares Quarterly Cash Dividend
January 28, 2026
From
Kenvue
Via
Business Wire
Looking for the most active stocks in the S&P500 index on Tuesday?
↗
January 27, 2026
Via
Chartmill
What's going on in today's session: S&P500 most active stocks
↗
January 26, 2026
Via
Chartmill
Johnson & Johnson 2026 Outlook: Chasing the $100 Billion Milestone Amidst Legal and Patent Hurdles
January 23, 2026
Following a resilient performance throughout 2025, healthcare giant Johnson & Johnson (NYSE: JNJ) has officially set its sights on a historic milestone for 2026. In its latest earnings report released...
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Economy
What's going on in today's session: S&P500 most active stocks
↗
January 23, 2026
Via
Chartmill
Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026
January 23, 2026
As of January 23, 2026, Johnson & Johnson (NYSE:JNJ) finds itself at a historic crossroads. After spending much of 2025 navigating the "patent cliff" of its blockbuster drug Stelara and finalizing its...
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Economy
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today